•  
  •  
 

Document Type

Original Article

Abstract

Background: Recent diabetes treatment recommendations state that weight reduction should be the rational and most practical method of treating Type 2 diabetes given the significance of obesity in the genesis of the disease. Bariatric surgery is increasingly used as the preferred therapy for people with extreme obesity, with the exception of certain pharmacological and nutritional therapies. Aim and Objectives: To examine the effectiveness of controlling T2DM in obese individuals with laparoscopic sleeve gastrectomy and laparoscopic mini-gastric bypass. Patients and methods: The Al-Azhar university hospitals hosted a randomized controlled trial that took place between May 2022 and August 2023. Using the closed envelopment approach, 60 obese individuals with T2DM were randomly allocated into two groups. Results: With respect to personal factors, biochemical features, medical characteristics, and operation time, the two groups did not differ statistically. Hospital stay, (FBS at baseline, at follow-up, and overall FBS change), and (BMI at baseline, at follow-up, and overall BMI reduction). Conclusion: In addition to helping patients lose weight, bariatric surgery (SG and MGB) is a metabolic procedure that can treat the majority of metabolic syndrome symptoms. It is also thought to be the gold standard for the maintenance management of type 2 diabetes in obese persons, and our research suggests that MGB has faster and more effective results with diabetes remission than those shown with SG.

Keywords

laparoscopic Sleeve Gastrectomy; Type2 Diabetes Mellitus; laparoscopic Mini Gastric Bypass; obese patients.

Subject Area

General Surgery

Download

Share

COinS